MeSH term
Frequency | Condition_Probility | Base Sequence | 9 | 0.0 |
Genotype | 2 | 0.0 |
Hepatitis delta Antigens | 2 | 15.0 |
Humans | 22 | 0.0 |
Molecular Sequence Data | 9 | 0.0 |
Nucleic Acid Conformation | 4 | 0.0 |
*RNA Editing | 8 | 19.0 |
Research Support, U.S. Gov't, P.H.S. | 15 | 0.0 |
Transfection | 4 | 0.0 |
Tumor Cells, Cultured | 4 | 0.0 |
Research Support, Non-U.S. Gov't | 15 | 0.0 |
Animals | 8 | 0.0 |
RNA Editing | 4 | 22.0 |
RNA, Messenger/chemistry/*genetics | 2 | 33.0 |
Adenosine Deaminase/metabolism | 4 | 20.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
Binding Sites | 3 | 0.0 |
Cell Nucleus/*metabolism | 2 | 0.0 |
Conserved Sequence | 2 | 0.0 |
Cytoplasm/metabolism | 2 | 0.0 |
Mice | 2 | 0.0 |
Recombinant Fusion Proteins/genetics/metabolism | 2 | 0.0 |
Adenosine Deaminase/*genetics | 2 | 8.0 |
Cell Line | 3 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
RNA Splicing | 2 | 0.0 |
Comparative Study | 4 | 0.0 |
Hydrolysis | 2 | 0.0 |
Species Specificity | 2 | 0.0 |
RNA Editing/*genetics | 5 | 29.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Substrate Specificity | 2 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
Female | 2 | 0.0 |
Male | 2 | 0.0 |
COS Cells | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction/methods | 2 | 0.0 |
Amino Acid Sequence | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Hela Cells | 2 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
